News

Raising awareness of the risk of post-traumatic hypopituitarism following a head injury must be increased among healthcare professionals, say campaigners. Thousands of people, in the UK alone ...
Researchers in China have carried out the first transplant of a pig liver, genetically modified to prevent immune rejection, into a brain-dead human patient. The transplant functioned for 10 days ...
Prof Vanessa Raymont of the University of Oxford, who is co-leading the READ-OUT trial. The UK government is providing £2 million ($2.6 million) in funding to allow digital assessment to be added ...
The EMA's human medicines committee has said it does not recommend approval of Eli Lilly's anti-amyloid Alzheimer's disease treatment Kisunla, saying its modest benefits don't outweigh its risks.
Observational research is core to drug development, helping researchers understand the natural history of diseases and the real-world impact of treatments on patients. Observational studies ...
BeiGene has decided to stop the development of its TIGIT-targeting drug ociperlimab in yet another setback for the drug class. The Nasdaq-listed company – which is planning to rebrand as BeOne ...
In the dark days of 2020, amid the global race for a COVID-19 vaccine, the UK showcased its world-class expertise in medical research. The swift development of the Oxford-AstraZeneca vaccine ...
Johnson & Johnson's third attempt to use bankruptcy proceedings to settle lawsuits claiming that its talc-based products harmed consumers has been rejected. In a Houston, Texas court, Judge ...
The UK stands at the cusp of a new era of medical breakthroughs, fuelled by the increased use of data and the recent plans to open NHS data reserves to improve the development and creation of ...
Eyecare giant Alcon has bought a majority stake in cell therapy start-up Aurion Biotech, replacing the company's chief executive, in the culmination of a months-long struggle for control.
Novartis has claimed accelerated approval from the FDA for Vanrafia, one of a trio of therapies it hopes will revolutionise the treatment of rare kidney disease IgA nephropathy (IgAN). Vanrafia ...
In the feature ‘Successfully navigating the complexity of market access across Europe to improve health equity’, originally published in the European Biopharmaceutical Review, EVERSANA General ...